Research Article

Combinatorial Mutagenesis and Selection to Understand and Improve Yeast Promoters

Table 1

Strains and vectors used in this study.

Strain or plasmidDescriptiona,b,cReference or source

E.coli strains
 DH5αGeneral cloning host.BRL
 ER2925Host used for cloning experiments involving methylation-sensitive restriction enzymes.NEB
P. pastoris strain
 GS115Host used for all of the P. pastoris screening and growth experiments.Invitrogen
Vectors
 pIB11Bacterial RK2-based expression vector harboring Pm/xylS regulatory promoter system with the bla gene as reporter, .[6]
 pGL3-control  vectorFirefly luciferase reporter vector, .Promega
 pBGP1P. pastoris episomal expression vector harbouring the promoter. E. coli-P. pastoris shuttle vector, , .[19]
 pPICZ AP. pastoris expressional vector harbouring the promoter. E. coli-P. pastoris shuttle vector, .Invitrogen
 pPPE3pBGP1 derivative in which the three BspHI restriction sites are deleted including one situated in the promoter by using site-directed mutagenesis with primer pair 1, 2, and 3, , . This study
 pPPE8pPPE3 derivative in which a BspHI restriction enzyme site was inserted in the start of the zeocin-resistance gene by using site-directed mutagenesis with primer pair 4, .This study
 pPPE10pPPE8 derivative in which the zeocin-resistance gene was substituted with the kanamycin-resistance gene from plasmid pIB11. The gene was amplified from pIB11 with primer pair 5 and end digested with BspHI and EcoRV prior to ligation into the corresponding sites of pPPE8, , , .This study
 pPPE11pPPE10 derivative in which a NcoI restriction enzyme site was inserted in the start of the Alpha signal by using site-directed mutagenesis with primer pair 6, , , .This study
 pPPE12pPPE11 derivative in which the zeocin-resistance gene was inserted as reporter for the modified promoter. The zeocin-resistance gene was amplified from plasmid pBGP1 with primer pair 7 and end digested with NcoI and NotI prior to ligation into the corresponding sites of pPPE11, , , .This study
 pPPE17pPPE12 derivative in which the modified promoter was substituted with the . The promoter was amplified from pPICZ A with primer pair 8 and end digested with SpeI and NcoI prior to ligation into the corresponding sites of pPPE12, , , .This study
 pIPA1pPICZ A derivative in which the BspHI restriction enzyme site in the promoter is deleted by using site directed mutagenesis with primer pair 9, .This study
 pIPA4pIPA1 derivative in which an EcoRI restriction enzyme site is inserted directly upstream of the putative TATA-box in the promoter by using site-directed mutagenesis with primer pair 10, .This study
 pIPA5pIPA4 derivative in which a NheI restriction enzyme site is inserted downstream of the transcriptional start site in the promoter by using site-directed mutagenesis with primer pair 11, .This study
 pPPE20Similar to pPPE17 except for that the promoter was substituted with the modified promoter from plasmid pIPA5. The promoter was amplified from plasmid pIPA5 with primer pair 12 and end digested with SpeI and NcoI prior to ligation into the corresponding sites of pPPE12, , , .This study
 pPPE22Similar to pPPE17 except for that the promoter was substituted with the wild-type promoter from plasmid pBGP1 by subcloning the SpeI/MfeI fragment from plasmid pBGP1 into the corresponding sites of plasmid pPPE12, , , .This study
 pPPE35Similar to pPPE17 except for that the gene is substituted with the luc+ gene (encoding firefly luciferase). The luc+ gene was amplified from plasmid pGL3-control vector with primer pair 13 and end digested with NcoI and NotI prior to ligation into the corresponding sites of pPPE17, , , .This study
 pPPE50Similar to pPPE20 except for that a KpnI restriction enzyme site is inserted in the promoter about 90 base pairs upstream of the EcoRI restriction enzyme site by using site-directed mutagenesis with primer pair 14, , , .This study

aAp: ampicillin; Km: kanamycin; Zc: Zeocin, G418: aminoglycoside antibiotic.
bSequences of the primer pairs are listed in Table 2.
cThe target region was subcloned and verified by sequencing for all of the site-directed mutagenesis applications. Also, all cloned regions amplified by PCR were verified by sequencing.